Cargando…
HLA class I and II genotype of the NCI-60 cell lines
Sixty cancer cell lines have been extensively characterized and used by the National Cancer Institute's Developmental Therapeutics Program (NCI-60) since the early 90's as screening tools for anti-cancer drug development. An extensive database has been accumulated that could be used to sel...
Autores principales: | Adams, Sharon, Robbins, Fu-Meei, Chen, Deborah, Wagage, Devika, Holbeck, Susan L, Morse, Herbert C, Stroncek, David, Marincola, Francesco M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555742/ https://www.ncbi.nlm.nih.gov/pubmed/15748285 http://dx.doi.org/10.1186/1479-5876-3-11 |
Ejemplares similares
-
Associations between HLA Class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians
por: Li, Xin, et al.
Publicado: (2007) -
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
por: Ascierto, Maria Libera, et al.
Publicado: (2011) -
Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification
por: Adams, Sharon D, et al.
Publicado: (2004) -
An integrated analysis of molecular aberrations in NCI-60 cell lines
por: Yeang, Chen-Hsiang
Publicado: (2010) -
Expression of MicroRNAs in the NCI-60 Cancer Cell-Lines
por: Patnaik, Santosh K., et al.
Publicado: (2012)